COVID-19 vaccines: The status and perspectives in delivery points of view
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 vaccines: The status and perspectives in delivery points of view
Authors
Keywords
Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Immune response, Neutralizing antibodies, Vaccine delivery
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 170, Issue -, Pages 1-25
Publisher
Elsevier BV
Online
2020-12-25
DOI
10.1016/j.addr.2020.12.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Positive RT-PCR Test Results in Patients Recovered From COVID-19
- (2020) Lan Lan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
- (2020) Fang Jiang et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Immune Responses to Viral Gene Therapy Vectors
- (2020) Jamie L. Shirley et al. MOLECULAR THERAPY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Engineering adeno-associated virus vectors for gene therapy
- (2020) Chengwen Li et al. NATURE REVIEWS GENETICS
- Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
- (2020) Emmie de Wit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CT Manifestations of Two Cases of 2019 Novel Coronavirus (2019-nCoV) Pneumonia
- (2020) Yicheng Fang et al. RADIOLOGY
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
- (2020) Syed Faraz Ahmed et al. Viruses-Basel
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
- (2020) Amy S. Espeseth et al. npj Vaccines
- The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
- (2020) Weilong Shang et al. npj Vaccines
- Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
- (2020) Ahmet Kursat Azkur et al. ALLERGY
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
- (2020) Stephen A. Lauer et al. ANNALS OF INTERNAL MEDICINE
- Convalescent plasma in Covid-19: Possible mechanisms of action
- (2020) Manuel Rojas et al. AUTOIMMUNITY REVIEWS
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- An Infectious cDNA Clone of SARS-CoV-2
- (2020) Xuping Xie et al. Cell Host & Microbe
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
- (2020) Li Guo et al. CLINICAL INFECTIOUS DISEASES
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
- (2020) Hai-qiong Yu et al. EUROPEAN RESPIRATORY JOURNAL
- Treatments in the COVID-19 pandemic: an update on clinical trials
- (2020) Yan Yi Tao et al. EXPERT OPINION ON EMERGING DRUGS
- Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
- (2020) Mona Fani et al. Future Virology
- Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19
- (2020) Hisashi Kai et al. HYPERTENSION RESEARCH
- Immunology of COVID-19: current state of the science
- (2020) Nicolas Vabret et al. IMMUNITY
- SARS-CoV-2 Vaccines: Status Report
- (2020) Fatima Amanat et al. IMMUNITY
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate
- (2020) Manuel Becerra‐Flores et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Convalescent Plasma to Treat COVID-19
- (2020) John D. Roback et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2
- (2020) Wanbing Liu et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis
- (2020) Ju Kim et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage
- (2020) Jingyuan Liu et al. Journal of Translational Medicine
- Human leukocyte antigen susceptibility map for SARS-CoV-2
- (2020) Austin Nguyen et al. JOURNAL OF VIROLOGY
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
- (2020) Pedro M Folegatti et al. LANCET INFECTIOUS DISEASES
- Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
- (2020) Tran Thi Nhu Thao et al. NATURE
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
- (2020) Irani Thevarajan et al. NATURE MEDICINE
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
- (2020) Waradon Sungnak et al. NATURE MEDICINE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developing Covid-19 Vaccines at Pandemic Speed
- (2020) Nicole Lurie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
- (2020) Neeltje van Doremalen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS‐CoV‐2 infection‐induced immune responses: friends or foes?
- (2020) Keying Li et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
- (2020) Yan Wu et al. SCIENCE
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
- (2020) Shibo Jiang et al. TRENDS IN IMMUNOLOGY
- Immunogenicity of a DNA vaccine candidate for COVID-19
- (2020) Trevor R. F. Smith et al. Nature Communications
- Immunomodulation in COVID-19
- (2020) Nicholas E Ingraham et al. Lancet Respiratory Medicine
- Correction: Immunodominant SARS Coronavirus Epitopes in Humans Elicited Both Enhancing and Neutralizing Effects on Infection in Non-human Primates
- (2020) Qidi Wang et al. ACS Infectious Diseases
- Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
- (2020) Angelika Wagner et al. Frontiers in Immunology
- High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice — Skagit County, Washington, March 2020
- (2020) Lea Hamner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
- (2020) Yonggang Zhou et al. National Science Review
- Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
- (2020) Eun Kim et al. EBioMedicine
- The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
- (2020) Xi Wang et al. Cell Discovery
- Progress and Prospects on Vaccine Development against SARS-CoV-2
- (2020) Jinyong Zhang et al. Vaccines
- Nanotechnology for COVID-19: Therapeutics and Vaccine Research
- (2020) Gaurav Chauhan et al. ACS Nano
- Prevalence of Asymptomatic SARS-CoV-2 Infection
- (2020) Daniel P. Oran et al. ANNALS OF INTERNAL MEDICINE
- Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
- (2020) Emanuel Della-Torre et al. ANNALS OF THE RHEUMATIC DISEASES
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
- (2020) Lianpan Dai et al. CELL
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
- (2020) Andrea Padoan et al. CLINICA CHIMICA ACTA
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Aerosol Transmission of SARS-CoV-2? Evidence, Prevention and Control
- (2020) Song Tang et al. ENVIRONMENT INTERNATIONAL
- SARS-CoV-2 does not replicate in embryonated hen’s eggs or in MDCK cell lines
- (2020) Ian G Barr et al. Eurosurveillance
- SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
- (2020) Giovanni Salvatori et al. Journal of Translational Medicine
- The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
- (2020) Noton K. Dutta et al. JOURNAL OF VIROLOGY
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
- (2020) Eskild Petersen et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 Vaccine Development: Current Status
- (2020) Gregory A. Poland et al. MAYO CLINIC PROCEEDINGS
- Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
- (2020) Qiangzhe Zhang et al. NANO LETTERS
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- Potently neutralizing and protective human antibodies against SARS-CoV-2
- (2020) Seth J. Zost et al. NATURE
- A perspective on potential antibody-dependent enhancement of SARS-CoV-2
- (2020) Ann M. Arvin et al. NATURE
- Next-generation vaccine platforms for COVID-19
- (2020) Debby van Riel et al. NATURE MATERIALS
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Age-dependent effects in the transmission and control of COVID-19 epidemics
- (2020) Nicholas G. Davies et al. NATURE MEDICINE
- Dexamethasone nanomedicines for COVID-19
- (2020) Twan Lammers et al. Nature Nanotechnology
- Immune-mediated approaches against COVID-19
- (2020) Helena F. Florindo et al. Nature Nanotechnology
- COVID-19 vaccine development and a potential nanomaterial path forward
- (2020) Matthew D. Shin et al. Nature Nanotechnology
- Potential neurological effects of severe COVID-19 infection
- (2020) Domenico Nuzzo et al. NEUROSCIENCE RESEARCH
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules
- (2020) Ashish Prasad et al. PLANT CELL REPORTS
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- (2020) Alina Baum et al. SCIENCE
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
- (2020) Supriya Ravichandran et al. Science Translational Medicine
- SARS-CoV-2 viral load predicts COVID-19 mortality
- (2020) Elisabet Pujadas et al. Lancet Respiratory Medicine
- Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19
- (2020) Sirle Saul et al. ACS Infectious Diseases
- COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
- (2020) Young Hun Chung et al. ACS Nano
- Leveraging mRNA Sequences and Nanoparticles to Deliver SARS‐CoV‐2 Antigens In Vivo
- (2020) Chunxi Zeng et al. ADVANCED MATERIALS
- Monoclonal antibody as a potential anti-COVID-19
- (2020) Leila Jahanshahlu et al. BIOMEDICINE & PHARMACOTHERAPY
- Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy
- (2020) Mahesh Jayaweera et al. ENVIRONMENTAL RESEARCH
- Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
- (2020) Tania Gupta et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Corticosteroids in COVID-19 ARDS
- (2020) Hallie C. Prescott et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
- (2020) Alessandro Gozzetti et al. LEUKEMIA
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
- (2020) Yanchun Peng et al. NATURE IMMUNOLOGY
- Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health
- (2020) Chelsea N. Fries et al. Nature Nanotechnology
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis
- (2020) Eric A. Coomes et al. REVIEWS IN MEDICAL VIROLOGY
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors
- (2020) Alfonso Trezza et al. Scientific Reports
- Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
- (2020) Rudra P. Saha et al. Frontiers in Pharmacology
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- A materials-science perspective on tackling COVID-19
- (2020) Zhongmin Tang et al. Nature Reviews Materials
- Natural killer cell immunotypes related to COVID-19 disease severity
- (2020) Christopher Maucourant et al. Science Immunology
- Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19
- (2020) Mohammed Osman et al. Blood Advances
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
- (2020) Lizhou Zhang et al. Nature Communications
- Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Uganda and Tanzania
- (2019) Zacchaeus Anywaine et al. JOURNAL OF INFECTIOUS DISEASES
- T Follicular Helper Cell Biology: A Decade of Discovery and Diseases
- (2019) Shane Crotty IMMUNITY
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
- (2019) Liu Vaccines
- Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency
- (2019) Brian Truong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
- (2019) Chean Yeah Yong et al. Frontiers in Microbiology
- Cold chain transportation decision in the vaccine supply chain
- (2019) Qi Lin et al. EUROPEAN JOURNAL OF OPERATIONAL RESEARCH
- Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination
- (2019) Janina M. Jansen et al. JOURNAL OF CLINICAL VIROLOGY
- A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults
- (2019) Morven Wilkie et al. VACCINE
- Engineering dendritic cell vaccines to improve cancer immunotherapy
- (2019) Caleb R. Perez et al. Nature Communications
- Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
- (2019) Thomas Sécher et al. Frontiers in Immunology
- A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice
- (2018) Xiaodan Cai et al. ANTIVIRAL RESEARCH
- Hydroxychloroquine: An old drug with new relevance
- (2018) E. A. SHIPPEY et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
- (2018) Waleed H. Mahallawi et al. CYTOKINE
- Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research
- (2018) Hanan Al-Lawati et al. Expert Opinion on Drug Delivery
- Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine
- (2018) Dominik Hartl et al. Journal of Innate Immunity
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
- (2018) Dan H Barouch et al. LANCET
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
- (2018) Robert Q. Le et al. ONCOLOGIST
- MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape
- (2018) Vineet D. Menachery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
- (2018) Mun Peak Nyon et al. VACCINE
- Author Correction: Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
- (2018) Haipeng Liu et al. Scientific Reports
- Development of novel vaccine vectors: Chimpanzee adenoviral vectors
- (2018) Jingao Guo et al. Human Vaccines & Immunotherapeutics
- An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques
- (2018) Yupeng Feng et al. Emerging Microbes & Infections
- Host Immune Response to Influenza A Virus Infection
- (2018) Xiaoyong Chen et al. Frontiers in Immunology
- Synthesis at the interface of virology and genetic code expansion
- (2018) Rachel E Kelemen et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Virus-like particle vaccines: immunology and formulation for clinical translation
- (2018) Braeden Donaldson et al. Expert Review of Vaccines
- DNA Vaccines—How Far From Clinical Use?
- (2018) Dominika Hobernik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- Nanoparticle Vaccines Against Infectious Diseases
- (2018) Rashmirekha Pati et al. Frontiers in Immunology
- Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
- (2018) Nataschja I. Ho et al. Frontiers in Immunology
- Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
- (2017) S Guan et al. GENE THERAPY
- Novel viral vectors in infectious diseases
- (2017) Ian R. Humphreys et al. IMMUNOLOGY
- Bacteria isolated from lung modulate asthma susceptibility in mice
- (2017) Aude Remot et al. ISME Journal
- Airway T cells protect against RSV infection in the absence of antibody
- (2017) E Kinnear et al. Mucosal Immunology
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches
- (2017) Nisreen MA Okba et al. Current Opinion in Virology
- Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
- (2017) John J. Suschak et al. Human Vaccines & Immunotherapeutics
- CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function
- (2017) Arata Takeuchi et al. Frontiers in Immunology
- Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
- (2017) Vincent J. Munster et al. npj Vaccines
- Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens
- (2017) Victor Riitho et al. Scientific Reports
- Dendritic cell-based immunotherapy
- (2016) Rachel L Sabado et al. CELL RESEARCH
- The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness
- (2016) Jeroen Luyten et al. HEALTH AFFAIRS
- Tissue-resident dendritic cells and diseases involving dendritic cell malfunction
- (2016) Keqiang Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Materials for non-viral intracellular delivery of messenger RNA therapeutics
- (2016) Kevin J. Kauffman et al. JOURNAL OF CONTROLLED RELEASE
- A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats
- (2016) Christina A. Rostad et al. JOURNAL OF VIROLOGY
- Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung
- (2016) K M Morabito et al. Mucosal Immunology
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Generation of influenza A viruses as live but replication-incompetent virus vaccines
- (2016) L. Si et al. SCIENCE
- Present Yourself! By MHC Class I and MHC Class II Molecules
- (2016) Kenneth L. Rock et al. TRENDS IN IMMUNOLOGY
- A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
- (2016) Wanbo Tai et al. VIROLOGY
- Roles of natural killer cells in antiviral immunity
- (2016) Stephen N Waggoner et al. Current Opinion in Virology
- Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
- (2016) Anurodh Shankar Agrawal et al. Human Vaccines & Immunotherapeutics
- Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3
- (2016) Pak-Yin Lui et al. Emerging Microbes & Infections
- Structure, Function, and Evolution of Coronavirus Spike Proteins
- (2016) Fang Li Annual Review of Virology
- Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
- (2015) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Systematic Identification of Factors for Provirus Silencing in Embryonic Stem Cells
- (2015) Bin Xia Yang et al. CELL
- Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
- (2015) Naru Zhang et al. Cellular & Molecular Immunology
- The innate immune function of airway epithelial cells in inflammatory lung disease
- (2015) Pieter S. Hiemstra et al. EUROPEAN RESPIRATORY JOURNAL
- Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production
- (2015) Sean R. McMaster et al. JOURNAL OF IMMUNOLOGY
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF INFECTIOUS DISEASES
- The emerging role of resident memory T cells in protective immunity and inflammatory disease
- (2015) Chang Ook Park et al. NATURE MEDICINE
- Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine
- (2015) Jose M. Jimenez-Guardeño et al. PLoS Pathogens
- In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome
- (2015) Oscar E. Simonson et al. Stem Cells Translational Medicine
- Interferon-Stimulated Genes: A Complex Web of Host Defenses
- (2014) William M. Schneider et al. Annual Review of Immunology
- Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
- (2014) F. Yasui et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma-Homing CD4 T Cells
- (2014) S. Sakai et al. JOURNAL OF IMMUNOLOGY
- Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine
- (2014) N. Iwata-Yoshikawa et al. JOURNAL OF VIROLOGY
- Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection
- (2014) R. Channappanavar et al. JOURNAL OF VIROLOGY
- Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4
- (2014) N. van Doremalen et al. JOURNAL OF VIROLOGY
- The contribution of vaccination to global health: past, present and future
- (2014) B. Greenwood PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen
- (2014) Jiaming Lan et al. PLoS One
- History of vaccination
- (2014) S. Plotkin PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study
- (2014) Guoping Zheng et al. RESPIRATORY RESEARCH
- Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
- (2014) Christopher M. Coleman et al. VACCINE
- How advances in immunology provide insight into improving vaccine efficacy
- (2014) Mark K. Slifka et al. VACCINE
- Mucosal Resident Memory CD4 T Cells in Protection and Immunopathology
- (2014) Damian Lanz Turner et al. Frontiers in Immunology
- Differential Roles of Lung Dendritic Cell Subsets Against Respiratory Virus Infection
- (2014) Tae Hoon Kim et al. Immune Network
- Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection
- (2013) Qiang Liu et al. ACTA PHARMACOLOGICA SINICA
- Virus-like particles for the prevention of human papillomavirus-associated malignancies
- (2013) Joshua W Wang et al. Expert Review of Vaccines
- Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease
- (2013) X. Yang et al. JOURNAL OF GENERAL VIROLOGY
- Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein
- (2013) C. Fett et al. JOURNAL OF VIROLOGY
- Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist
- (2013) D. Niemeyer et al. JOURNAL OF VIROLOGY
- Lung niches for the generation and maintenance of tissue-resident memory T cells
- (2013) D L Turner et al. Mucosal Immunology
- Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer
- (2013) Anne Flörcken et al. Human Vaccines & Immunotherapeutics
- Dendritic cell-based vaccines: barriers and opportunities
- (2012) Jessica A Cintolo et al. Future Oncology
- Cellular immune reactions in the lung
- (2012) Mike Hasenberg et al. IMMUNOLOGICAL REVIEWS
- Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity
- (2012) Xiaodong Jiang et al. NATURE
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
- (2012) Daniel X. Johansson et al. PLoS One
- Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- Artificial Molecular Clamp: A Novel Device for Synthetic Polymerases
- (2011) Yoshinori Takashima et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection
- (2011) J. R. Teijaro et al. JOURNAL OF IMMUNOLOGY
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
- (2011) M. Bolles et al. JOURNAL OF VIROLOGY
- Therapeutic siRNA silencing in inflammatory monocytes in mice
- (2011) Florian Leuschner et al. NATURE BIOTECHNOLOGY
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8+ T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848
- (2011) Kai Zhao et al. VACCINE
- Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis
- (2011) Marie Ballester et al. VACCINE
- Lopinavir/Ritonavir
- (2010) Jamie D. Croxtall et al. DRUGS
- Overview of the immune response
- (2010) David D. Chaplin JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Acts as a Dominant Immunogen Revealed by a Clustering Region of Novel Functionally and Structurally Defined Cytotoxic T‐Lymphocyte Epitopes
- (2010) Jun Liu et al. JOURNAL OF INFECTIOUS DISEASES
- Rationalizing the development of live attenuated virus vaccines
- (2010) Adam S Lauring et al. NATURE BIOTECHNOLOGY
- Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8+ T cell responses to influenza
- (2010) André Ballesteros-Tato et al. NATURE IMMUNOLOGY
- A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
- (2010) J.E. Ledgerwood et al. VACCINE
- Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection
- (2009) J. Chen et al. JOURNAL OF VIROLOGY
- Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF- B Signaling
- (2009) M. Frieman et al. JOURNAL OF VIROLOGY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- Challenges in the development of an HIV-1 vaccine
- (2008) Dan H. Barouch NATURE
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
- Basic science of the innate immune system and the lung
- (2008) Nazia Chaudhuri et al. Paediatric Respiratory Reviews
- Effects of Different Immunization Protocols and Adjuvant on Antibody Responses to Inactivated SARS-CoV Vaccine
- (2008) Weiwei Gai et al. VIRAL IMMUNOLOGY
- SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum
- (2008) Kèvin Knoops et al. PLOS BIOLOGY
- Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease
- (2007) Luis Enjuanes et al. VIRUS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More